Author:
ÇINAR Alev,INCE Semra,GÖKER Ülkü Nur
Publisher
The European Research Journal
Reference14 articles.
1. 1. Roses DF, Karp NS, Oratz R, Dubin N, Harris MN, Speyer J, et al. Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet 1991;172:262-8.
2. 2. Reinhardt MJ, Joe, AY, Jaeger U, Huber A, Matthies A, Bucerius J, et al. Diagnostic performance of whole-body 18FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006;24:1178-87.
3. 3. Malik D, Sood A, Mittal BR, Basher RK, Bhattacharya A, Singh G. Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in restaging and prognosis of recurrent melanoma after curative surgery. World J Nucl Med 2019;18:176.
4. 4. Garcia GA, Fernandez F, Satue E, Buelta L, Val-Bernal J. Metastasis of malignant neoplasms of skeletal muscle. Rev Esp Oncol 1984;31:57-67.
5. 5. Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, et al. Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Eur J Nucl Med Mol Imaging 2018;45:376-83.